A biopharma company on the Oslo Stock Exchange, in this weeks analysis!
Aksjeanalyser.com takes a closer look at a share that could multiply over the next 6-12 months!
Nykode Therapeutics ASA
(ticker on Oslo Stock Exchange: NYKD)
The stock has triggered several positive technical signals recently, and the technical picture indicates that it may now be at a favorable level to buy the stock.
It should be noted that biotech stocks are highly volatile, so you need to be aware that the risk of investing in these stocks is very high. But the potential is also interesting if the biotech company succeeds with its research, drugs, and treatments.
Aksjeanalyser.com finds the Nykode Therapeutics share very interesting and exciting. Read more below under the technical analysis of the stock.
About the company, Nykode Therapeutics ASA
(ticker on Oslo Stock Exchange: NYKD)
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapies. The company focuses on the development of individualized cancer neoantigen vaccines using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006, and is headquartered in Oslo, Norway.
With the current share price, the company has a market capitalization of around NOK 688 million.
For more information about the company, visit their website here.
Technical Analysis of Nykode Therapeutics ASA
(ticker on Oslo Stock Exchange: NYKD)
Nykode Therapeutics stock (NYKD) has triggered several positive technical signals recently. The stock has broken above both the 50-day and 200-day moving averages, and the 50-day moving average is now breaking above the 200-day moving average (the so-called Golden Cross signal).
This is a strong technical buy signal, indicating that both the short and long-term trends for the stock have turned from negative to positive.
The stock has also broken above an important technical resistance level around NOK 2.00, and the stock is now finding significant technical support around the NOK 2.00 level, where there is also solid support down towards both the 50-day and 200-day moving averages.
The share is currently consolidating between NOK 2.00 and NOK 3.00, and an established breach of one of these levels will provide important technical signals about the further development of the share.
The BEST model in Vikingen is also in a buy signal for Nykode Therapeutics’ share (ticker NYKD). This popular and effective technical analysis model was developed by Peter Östevik. He finalized the the BEST model around 2019, and after 30 years of experience in technical analysis and Vikingen Financial Software.
Based on the overall technical picture that Nykode Therapeutics (ticker NYKD) is now showing, Aksjeanalyser.com views the stock as an interesting and exciting buy candidate at the current price level.
The potential for the share is estimated to be up to NOK 2.80 – 3.00 in the short term (1-3 weeks), and in the event of a break above the NOK 3.00 level, the share is estimated to have a potential of between NOK 5.00 – 10.00 in 6-12 months’ time.
As mentioned, the risks of investing in biotech companies are high, but the rewards are also very high if the companies succeed with their research and medicines for the treatment of serious diseases.
What could potentially change the current positive technical picture for the Nykode share would be if it were to have an established break below a currently important technical support level around NOK 2.00, and below the 50-day and 200-day moving averages (which today are both around the NOK 2.00 level).
Time for Vikingen’s best discount of the year!
Welcome to take advantage of Vikingen’s BLACK WEEK offer!
The whole week from November 24th to 30th, 2025, you get a 40% discount on everything in Vikingens online store!
- Here’s how you can take advantage of the offer:
Use this link to get to our online store
Choose your language and currency
Choose from Vikingen’s four basic programs and all add-ons
Go to checkout, fill in your details, and use the code BLK2025
Done! You will receive an email from Viking with your details
Any questions? Feel free to send an email to support(at)vikingen.se
The Black Week offer cannot be combined with other offers.
Vikingen Financial Software reminds you that past positive results do not always indicate future profits and that all trading is at your own risk.
Sincerely yours
